Sales reported at Rs 0.51 crore
Sales decline 20.29% to Rs 2.75 crore
With resurgence in Omicron cases, ICRA expects partial cost towards children’s vaccination and booster shots for the adult population to be a part of the upcoming budgetary allotment towards the sector.
Co-invent industry-specific technical and operations solutions for Digital Assets, DeFi, cryptocurrencies and Web 3.0.
Japan share market finished session lower on Friday, 21 January 2022, as sentiment was hit by overnight losses on Wall Street and deepening uncertainty over Japans economic recovery after widening of the COVID-19 quasi-state of emergency to more Japanese prefectures. Meanwhile, market sentiments also dampened by yen appreciation to upper 113-range against greenback as investors fled to the perceived safety of the yen. Total 16 […]
Company’s revenue for the 9M period ending December 2021 stood at Rs 1204.46 crores against Rs 839.97 crores for 9M ending December 2020.
Economic Initiative ‘SEOUL SPOONING 2022’ Announced for MIR4
Sales rise 30.94% to Rs 18025.34 crore
Sales rise 18.67% to Rs 36.04 crore
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
